Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-08-12 Purchase | 2022-08-16 8:19 pm | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 10,000 | $2.8432 | $28,433 | 55,390 (Indirect Direct) | View |
2021-08-13 Purchase | 2021-08-13 9:01 pm | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 5,000 | $7.5613 | $37,807 | 34,140 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-01 Option Award | 2024-03-05 4:34 pm | N/A 2034-03-01 | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 160,000 | $0 | 160,000 (Direct) | View |
2023-02-27 Option Award | 2023-03-01 5:19 pm | N/A 2033-02-27 | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 160,000 | $0 | 160,000 (Direct) | View |
2022-05-12 Option Award | 2022-05-13 5:09 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 10,000 | $3.28 | 44,140 (Indirect) | View |
2022-02-25 Option Award | 2022-02-25 8:10 pm | N/A 2032-02-25 | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 140,000 | $0 | 140,000 (Direct) | View |
2021-06-14 Option Award | 2021-08-04 8:01 pm | N/A 2031-06-14 | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 326,526 | $0 | 326,526 (Direct) | View |
Ownership | 2021-06-09 9:42 pm | N/A N/A | Nautilus Biotechnology Inc. | NAUT | Murphy Matthew B. General Counsel | 0 | $0 | 29,140 (Indirect) | View |